Development of Solventless Pharmaceutical Technique for Manufacture of Pharmaceuticals

被引:0
|
作者
Kondo, Keita [1 ]
机构
[1] Meijo Univ, Fac Pharm, Dept Ind Pharm, 150 Yagotoyama,Tempaku Ku, Nagoya 4688503, Japan
关键词
solventless mixing; dry coating; mechanofusion; polymethacrylate; ethylcellulose; RELEASE; POWDER; WATER;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of our study was to develop a solventless drug pelletization and polymer coating technique for pharmaceutical manufacturing. This review describes a dry coating technique using a mechanical powder processor and a V-shaped blender to produce coated pellets or tablets by mechanically mixing polymer particles and core materials (such as drug pellets and uncoated tablets) without the need for a solvent. First, aqueous latexes comprising colloidal polymethacrylates and ethylcellulose were solidified by freeze drying to produce polymer particles for the dry coating process. These particles and the cores were then subjected to mechanical powder processing or V-shaped blending to provide coated formulations with controlled-release characteristics. Polymer coating was achieved by using agglomerates comprising assembled colloidal polymer. The agglomerated polymer was easily pulverized during the mixing treatments due to its loose structure (the lack of close contacts between the colloidal particles), and the resulting fine polymer with high adhesiveness was deposited on the cores. Colloidal polymer dispersed in aqueous latex tends to coagulate in the freeze-drying process due to condensation of the dispersion, yielding dense agglomerates with poor coating characteristics. The presence of surfactants (such as sodium lauryl sulfate) in the latex can prevent adhesion between colloidal particles in the freeze-drying process, providing loosely structured agglomerates suitable for dry coating. Dry coating with a V-shaped blender could thus be achieved with these polymer particles instead of having to use a mechanical powder processor.
引用
收藏
页码:919 / 930
页数:12
相关论文
共 50 条
  • [21] CONTAMINATION CONTROL IN THE MANUFACTURE OF STERILE PHARMACEUTICALS.
    Pietrowski, Robert
    Journal of the Society of Environmental Engineers, 1987, 26 (01): : 13 - 14
  • [22] Process analytical technology (PAT) in the manufacture of pharmaceuticals
    Clegg, I
    Hughes, D
    TCE, 2004, (758): : 23 - 25
  • [23] SELF-SUFFICIENCY IN THE MANUFACTURE OF BULK PHARMACEUTICALS
    HARRISON, FG
    DRUG & COSMETIC INDUSTRY, 1985, 137 (03): : 52 - &
  • [24] MANUFACTURE OF PHARMACEUTICALS IN A HOSPITAL PHARMACY - A POLICY GUIDELINE
    SHETH, BB
    RAY, MD
    CRIPPS, GW
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1970, 27 (02): : 140 - &
  • [25] Evaluating Change During Pharmaceutical Product Development and Manufacture-Comparability and Equivalence
    Chatfield, Marion J.
    Borman, Phil J.
    Damjanov, Ivana
    QUALITY AND RELIABILITY ENGINEERING INTERNATIONAL, 2011, 27 (05) : 629 - 640
  • [26] Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates
    Sun, Huihua
    Zhang, Hongfang
    Ee Lui Ang
    Zhao, Huimin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (07) : 1275 - 1284
  • [28] Lubiprostone Sucampo Pharmaceuticals Takeda Pharmaceutical
    Winpenny, JP
    IDRUGS, 2005, 8 (05) : 416 - 422
  • [29] New pharmaceuticals and pharmaceutical compounds.
    Zernik
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1929, 55 : 921 - 922
  • [30] Pharmaceutical formulation facilities as sources of pharmaceuticals
    Phillips, Patrick
    Smith, Steven
    Kolpin, Dana
    Zaugg, Steven
    Buxton, Herbert
    Furlong, Edward
    Esposito, Kathleen
    Stinson, Beverley
    TOXICOLOGY LETTERS, 2012, 211 : S16 - S17